Comparison Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
23:00:00 17/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +6.67% |
|
+3.97% | +4.73% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +6.67% | +3.97% | +4.73% | -5.26% | -57.75% | 329M |  | |  |
- Stock Market
- Stocks
- CATX Stock
- Charts Perspective Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
